A61M 1/3675
Deactivation
Official title: {Deactivation}
A61M1/3675 (Deactivation) appears on 89 US grants and 86 published applications in this corpus.
Search patents in A61M- Granted patents
- 89
- Published applications
- 86
- Assignees
- 50
- Inventors
- 158
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 4 |
| 2003 | 1 | 1 |
| 2004 | 4 | 4 |
| 2005 | 1 | 3 |
| 2006 | 1 | 1 |
| 2007 | 1 | 3 |
| 2008 | 1 | 3 |
| 2009 | 0 | 1 |
| 2010 | 3 | 6 |
| 2011 | 1 | 6 |
| 2012 | 6 | 9 |
| 2013 | 2 | 4 |
| 2014 | 10 | 7 |
| 2015 | 7 | 7 |
| 2016 | 2 | 5 |
| 2017 | 2 | 4 |
| 2018 | 2 | 8 |
| 2019 | 7 | 0 |
| 2020 | 2 | 2 |
| 2021 | 5 | 4 |
| 2022 | 0 | 1 |
| 2023 | 2 | 1 |
| 2024 | 3 | 1 |
| 2025 | 1 | 1 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Apparatus for extracorporeal treatment of blood including calculation of pre-blood pump infusion flow rate9 Jun 2026US 12,649,021 B2Gambro Lundia AB
- Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus3 Mar 2026US 12,564,666 B2Fresenius Medical Care Deutschland GmbH
- Cytopheresis cartridges and use thereof25 Nov 2025US 12,478,923 B2SeaStar Medical, Inc.
- Apparatus for extracorporeal blood treatment9 Apr 2024US 11,951,240 B2Gambro Lundia AB
- Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus5 Mar 2024US 11,918,724 B2Fresenius Medical Care Deutschland GmbH
- Cytopheresis cartridges and use thereof6 Feb 2025US 2025/0041804 A1SeaStar Medical, Inc.
- Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus2 May 2024US 2024/0139397 A1Fresenius Medical Care Deutschland GmbH
- Apparatus for extracorporeal blood treatment19 Jan 2023US 2023/0017204 A1Gambro Lundia AB
- Cytopheresis cartridges and use thereof9 Jun 2022US 2022/0177838 A1SeaStar Medical, Inc.
- Methods and systems for the detection and removal of pathogens from blood18 Nov 2021US 2021/0353843 A1Stichting Sanquin Bloedvoorziening
Most cited
By later US patents
- Autologous blood recovery membrane system and method473US 5,055,198 A1991
- Hemostatic system and components for extracorporeal circuit379US 6,733,471 B1Medtronic, Inc. · 2004
- Salvage of autologous blood via selective membrane/sorption technologies144US 5,858,238 ABaxter Research Medical, Inc. · 1999
- Device and process for extracorporeal treatment by citrate anticoagulant84US 7,351,218 B2Gambro Lundia AB · 2008
- Continuous hemodialysis using citrate83US 5,032,615 AThe Regents of the University of California · 1991